Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia

Clinical Infectious Diseases

Volumn 29, Issue 5, 1999, Pages 1128-1132

  Lina, Gerard ^a   Piémont, Yves ^b   Godail Gamot, Florence ^a   Bes, Michèle ^a   Peter, Marie Odile ^c   Gauduchon, Valérie ^a   Vandenesch, François ^a   Etienne, Jerome ^a  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c Hôpitaux Universitaires de Strasbourg   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCIDIN;

ARTICLE; BACTERIAL GENE; BACTERIAL PNEUMONIA; CELLULITIS; FURUNCULOSIS; GENE AMPLIFICATION; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN ABSCESS; SKIN INFECTION; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

BACTERIAL TOXINS; EXOTOXINS; HUMANS; LEUKOCIDINS; PNEUMONIA, BACTERIAL; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 0033496604     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313461     Document Type: Article

References (25)

1. 1. Archer GL. Staphylococcus aureas: a well-armed pathogen. Clin Infect Dis 1998;26:1179-81.
2. 2. Couppié P, Cribier B, Prévost G, Grosshans E, Piémont Y. Leukocidin from Staphylococcus aureus and cutaneous infections: an epidemiologic study. Arch Dermatol 1994;130:1208-9.
3. 3. Cribier B, Prévost G, Couppié P, Finck-Barbançon V, Grosshans E, Piémont Y. Staphylococcus aureus leukocidin: a new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology 1992;185:175-85.
4. 4. Prévost G, Couppié P, Prévost P, et al. Epidemiological data on Staphylococcus aureus strains producing synergohymenotropic toxins. J Med Microbiol 1995;42:237-45.
5. 5. Supersac G, Prévost G, Piémont Y. Sequencing of leucocidin R from Staphylococcus aureus P83 suggests that staphylococcal leucocidins and gamma-hemolysin are members of a single, two-component family of toxin. Infect Immun 1993;61:580-7.
6. 6. Prévost G, Supersac G, Colin D, et al. The new family of leucotoxins from Staphyloco0ccus aureus: structural and biological properties. In: Freer J, Aitken R, Alouf JE, et al., eds. Zentralbl Bakteriol Suppl 24. Stuttgart: Gustav Fischer Verlag, 1994:284-93.
7. 7. Finck-Barbançon V, Duportail G, Meunier O, Colin DA. Pore formation by two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochem Biophys Acta 1993;1182:275-82.
8. 8. Ward PD, Turner WH. Identification of staphylococcal Panton-Valentine leukocidin as a potent dermonecrotic toxin. Infect Immun 1980;28:393-7.
9. 9. König B, Prévost G, Piémont Y, König W. Fffect of Staphylococcus aureus leucocidins inflammatory mediator release from human granulocytes. J Infect Dis 1995;171:607-13.
10. 10. Hensler T, Köller M, Prévost G, Piémont Y, Köning W. GTP-binding proteins are involved in the modulated activity of human neutrophils treated with the Panton-Valentine leukocidin of Staphylococcus aureus. Infect Immun 1994;62:5281-9.
11. 11. Roberts SOB, Rook A. Bacterial infections. In: Rook A, Wilkinson DS, Ebling FJG, eds. Textbook of dermatology. Oxford: Blackwell Scientific, 1979:541-605.
12. 12. Petersdorf RG, Bennett IL. Infection of specific tissues and anatomic sites. In: Wintrobe MM, Thorn G, Adams RD, Braunwald K, Isselbacher KJ, Petersdorf RG, eds. Harrison's principles of internal medicine. New York: McGraw-Hill Book, 1974:754-61.
13. 13. Pingleton SK, Fagon JY, Leeper KV Jr. Patient selection for clinical investigation of ventilator-associated pneumonia: criteria for evaluating diagnostic techniques. Chest 1992;102:553S-6S.
14. 14. Durack DT, Lukes AS, Bright DK, the Duke Endocarditis Service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96:200-9.
15. 15. Chesney PJ. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev Infect Dis 1989;11(Suppl 1):S1-7.
16. 16. Gladstone GP, Van Heyningen WE. Staphylococcal leucocidins. Br J Exp Pathol 1957;38:123-37.
17. 17. Supersac G, Piémont Y, Kubina M, Prévost G, Foster TJ. Assessment of the role of gamma-toxin in experimental endophthalmitis using a hlg-deficient mutant of Staphylococcus aureus. Microb Pathog 1998;24:241-51.
18. 18. De Buyser ML, Morvan A, Grimont F, El Solh N. Characterization of Staphylacoccus species by ribosomal RNA gene restriction patterns. J Gen Microbiol 1989;135:989-9.
19. 19. Prévost G, Cribier B, Couppié P, et al. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 1995;63:4121-9.
20. 20. Kaneko J, Kimura T, Kawakami Y, Tomita T, Kamio Y. Panton-Valentine leukocidin genes in a phage-like particle isolated from mitomycin C treated Staphylococcus aureus V8 (ATCC49775). Biosci Biotechnol Biochem 1997;61:1960-2.
21. 21. Finck-Barbançon V, Prévost G, Piémont Y, Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol 1991;142:75-85.
22. 22. Leppard BJ, Seal DV, Colman G, Hallas G. The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol 1985;112:559-67.
23. 23. Olcay L, Secmeer G, Gogus S, Akcoren Z. Pathological cast of the month. Fatal hemorrhagic staphylococcal pneumonia. Arch Pediatr Adolesc Med 1995;149:925-6.
24. 24. Petros S, Eggers B, Heuer M, et al. Severe community acquired pneumonia due to Staphylococcus aureus. Intensive Care Med 1998;24:189.
25. 25. Kaneko J, Kimuca T, Narita S, Tomita T, Kamio Y. Complete nucleotide sequence and molecular characterization of the temperate staphylococcal bacteriophage phiPVI. carrying Panton-Valentine leukocidin genes. Gene 1998;215:57-67.